GlassScriptPhysician profile
Saima Jalal
NPI 1962599829
$2,346.40
in general payments reported to CMS, 2019-2025
23 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $250 · 2021: $132 · 2022: $128 · 2023: $344 · 2024: $574 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $377.52 | 2019-2025 | Hydrus Microstent, Tryptyr, Rocklatan |
| Regeneron Healthcare Solutions, INC. | $235.68 | 2021-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $214.25 | 2022-2025 | |
| Sight Sciences, INC. | $195.81 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Carl Zeiss Meditec, INC. | $178.13 | 2019 | |
| Rxsight INC | $177.84 | 2024 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Allergan, INC. | $175.57 | 2019-2022 | |
| Genentech USA, INC. | $122.74 | 2023-2025 | Vabysmo |
| Johnson & Johnson Surgical Vision, INC. | $105.94 | 2020 | |
| Beaver-Visitec International, INC. | $75.18 | 2019 | |
| New World Medical,INC. | $59.74 | 2024-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Novartis Pharmaceuticals Corporation | $59.39 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $59.11 | 2019-2025 | |
| Biotissue Holdings INC. | $49.13 | 2019-2021 | |
| Thea Pharma INC. | $48.50 | 2022-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $42.18 | 2019 | |
| Alimera Sciences, INC. | $39.66 | 2019 | |
| Rayner Intraocular Lenses Limited | $26.26 | 2024 | Rayone Aspheric, Omidria, Rayone Emv |
| Apellis Pharmaceuticals, INC. | $25.28 | 2023 | Syfovre |
| Harrow Eye, LLC | $23.45 | 2024 | Vevye |
| Bausch & Lomb Americas INC. | $19.01 | 2023 | Xiidra |
| Omeros Corporation | $18.17 | 2019 | |
| Ocular Therapeutix, INC. | $17.86 | 2023 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saima Jalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.